7Baggers
 Published on: 2025-11-15 19:11:00  newser.com Sun, 16 Nov 2025 01:11:00 GMT
 Henderson Jane, CFO of Apogee Therapeutics, sells $130k in stock  Investing.com Nigeria Sat, 15 Nov 2025 02:18:48 GMT
 Published on: 2025-11-13 23:54:39  newser.com Fri, 14 Nov 2025 05:54:39 GMT
 Apogee Therapeutics CEO Henderson sells $1.26 million in stock  Investing.com India Fri, 14 Nov 2025 02:05:07 GMT
 Henderson, Apogee Therapeutics CFO, sells $60k in stock  Investing.com Fri, 14 Nov 2025 01:52:38 GMT
 Apogee Therapeutics Executives Sell Shares  TradingView Fri, 14 Nov 2025 01:40:00 GMT
 published on: 2025-11-12 14:24:11  newser.com Wed, 12 Nov 2025 20:24:11 GMT
 published on: 2025-11-12 09:27:17  newser.com Wed, 12 Nov 2025 15:27:17 GMT
 published on: 2025-11-12 02:24:07  newser.com Wed, 12 Nov 2025 08:24:07 GMT
 Apogee Therapeutics stock hits 52-week high at 61.19 USD By Investing.com  Investing.com Nigeria Wed, 12 Nov 2025 08:18:16 GMT
 Apogee Therapeutics Reports Q3 2025 Financial Progress  TipRanks Wed, 12 Nov 2025 04:13:50 GMT
 Apogee Therapeutics’ Stock Surge: Is It Time To Jump In?  timothysykes.com Tue, 11 Nov 2025 22:04:00 GMT
 apogee therapeutics stock hits 52-week high at 61.19 usd by investing.com  Investing.com Canada Tue, 11 Nov 2025 16:35:02 GMT
 Why Apogee Therapeutics Shares Are Gaining Momentum  TipRanks Tue, 11 Nov 2025 15:38:20 GMT
 apogee therapeutics sees cash runway into 2h28  TipRanks Tue, 11 Nov 2025 08:35:24 GMT
 Decoding Apogee Therapeutics Inc (APGE): A Strategic SWOT Insigh  GuruFocus Tue, 11 Nov 2025 05:22:13 GMT
 understanding the setup: (apge) and scalable risk  news.stocktradersdaily.com Tue, 11 Nov 2025 01:50:02 GMT
 apogee therapeutics reports positive interim results for apg333 antibody  MarketScreener Mon, 10 Nov 2025 15:32:54 GMT
 published on: 2025-11-10 09:17:09  newser.com Mon, 10 Nov 2025 15:17:09 GMT
 apogee therapeutics reports q3 net loss $65m vs. $49m last year  TipRanks Mon, 10 Nov 2025 14:10:14 GMT
 apogee therapeutics q3 net loss widens  MarketScreener Mon, 10 Nov 2025 13:10:25 GMT
 Apogee Therapeutics Announces Positive Phase 1 Results  TipRanks Mon, 10 Nov 2025 12:55:23 GMT
 Apogee Therapeutics, Inc. SEC 10-Q Report  TradingView Mon, 10 Nov 2025 12:33:00 GMT
 Apogee Therapeutics Provides Pipeline Progress  TradingView Mon, 10 Nov 2025 12:31:15 GMT
 Apogee Therapeutics Announces Positive Interim Phase 1  GlobeNewswire Mon, 10 Nov 2025 12:00:00 GMT
 Apogee Therapeutics sees cash runway into 2H28  TipRanks Mon, 10 Nov 2025 08:00:00 GMT
 apogee therapeutics cmo sells $593,902 in shares by investing.com  Investing.com South Africa Sat, 08 Nov 2025 01:20:40 GMT
 apogee therapeutics cmo sells $593,902 in shares  Investing.com Sat, 08 Nov 2025 01:11:56 GMT
 Apogee Therapeutics CMO sells $593,902 in shares  Investing.com Fri, 07 Nov 2025 08:00:00 GMT
 apogee therapeutics (apge) to release earnings on tuesday  MarketBeat Wed, 05 Nov 2025 17:14:40 GMT
 published on: 2025-11-05 02:32:10  newser.com Wed, 05 Nov 2025 08:32:10 GMT
 apogee therapeutics stock price target raised by rbc capital to $70  Investing.com South Africa Tue, 04 Nov 2025 00:13:17 GMT
 analyst optimism surges for apogee therapeutics  AD HOC NEWS Mon, 03 Nov 2025 16:57:03 GMT
 apogee therapeutics stock price target raised by rbc capital to $70  Investing.com India Mon, 03 Nov 2025 15:39:08 GMT
 Apogee Therapeutics to Participate in Upcoming Conferences  GlobeNewswire Mon, 03 Nov 2025 12:30:00 GMT
 Apogee Therapeutics stock initiated with Buy rating at Craig-Hallum  Investing.com Mon, 03 Nov 2025 08:00:00 GMT
 RBC Capital Raises Apogee Therapeutics (APGE) Price Target to $7  GuruFocus Mon, 03 Nov 2025 08:00:00 GMT
 mizuho securities keeps their buy rating on apogee therapeutics (apge)  The Globe and Mail Thu, 30 Oct 2025 10:10:00 GMT

Apogee Therapeutics, Inc.
(NASDAQ:APGE) 

APGE stock logo

Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subc...

Founded: 2022
Sector: TECHNOLOGY
Industry: GENERAL

Share this website to your friends